| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2026 | 11 May 2026 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended on March 31 2026 and to consider the recommendation of Final Dividend for the Financial Year 2025-26 if any. Pursuant to Regulation 30 and 33 of SEBI LODR Regulations 2015, we are pleased to furnish the Audited Financial Results along with the Auditors Report for the financial year ended March 31, 2026. (As Per BSE Announcement Dated on: 26/05/2026) | ||
| Board Meeting | 11 Feb 2026 | 27 Jan 2026 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve The Unaudited Financial Results of the Company for the quarter ended on December 31 2025. Pursuant to Regulation 30 and 33 of SEBI LODR Regulations, 2025, we would like to inform you that the Board of Directors in its meeting held today i.e., February 11, 2026, approved the unaudited financial results for the quarter ended December 31, 2025. Attached the limited review report as received from Statutory Auditors. (As Per BSE Announcement Dated on: 11/02/2026) | ||
| Board Meeting | 7 Nov 2025 | 17 Oct 2025 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve The Board Meeting of the Company will be held on 07/11/2025 to take on record the unaudited financial results for the quarter ended on September 30 2025 and to consider declaration of Interim Dividend for FY 2025-26 and to fix record date for the same. We wish to inform you that Board of Directors in its meeting held today i.e., November 07, 2025 approved the unaudited financial results for the quarter and half year ended September 30, 2025 and declared an interim dividend of Rs. 90/- per equity share of Rs. 10/- each for FY 2025-26 (As Per BSE Announcement Dated on 07.11.2025) | ||
| Board Meeting | 6 Aug 2025 | 21 Jul 2025 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30, 2025 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Outcome of Board Meeting of the Company held on August 06, 2025. (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 11 Jun 2025 | 11 Jun 2025 |
| Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, we wish to inform you that the Board of Directors at their duly convened meeting held on June 11, 2025, considered, noted, and approved the changes in the directorate of the Company. | ||
The business also said that the board of directors recommended a dividend of ₹35 per share. However, details not disclosed yet.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
